Maria Luisa Guerrera, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Waldenstrom Macroglobulinemia | 26 | 2024 | 1077 | 2.530 |
Why?
|
Myeloid Differentiation Factor 88 | 20 | 2024 | 583 | 2.310 |
Why?
|
Receptors, CXCR4 | 11 | 2021 | 729 | 1.480 |
Why?
|
Adenine | 14 | 2024 | 993 | 1.150 |
Why?
|
Piperidines | 14 | 2024 | 1664 | 0.860 |
Why?
|
Pyrazoles | 9 | 2024 | 2024 | 0.570 |
Why?
|
Pyrimidines | 9 | 2024 | 3050 | 0.510 |
Why?
|
Mutation | 19 | 2024 | 30243 | 0.440 |
Why?
|
Chromosome Deletion | 1 | 2018 | 1390 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-hck | 3 | 2022 | 46 | 0.420 |
Why?
|
Lymphoma, B-Cell | 3 | 2022 | 945 | 0.290 |
Why?
|
Protein Kinase Inhibitors | 5 | 2024 | 5709 | 0.250 |
Why?
|
Point Mutation | 3 | 2021 | 1596 | 0.230 |
Why?
|
Sulfonamides | 2 | 2024 | 1988 | 0.210 |
Why?
|
Lymphoma | 2 | 2021 | 1907 | 0.160 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2024 | 5342 | 0.150 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1427 | 0.140 |
Why?
|
Amino Acid Substitution | 2 | 2019 | 1744 | 0.140 |
Why?
|
Paracrine Communication | 1 | 2018 | 278 | 0.130 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1489 | 0.130 |
Why?
|
Lung Injury | 1 | 2020 | 435 | 0.120 |
Why?
|
Receptor, Notch2 | 1 | 2014 | 90 | 0.120 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2015 | 225 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2019 | 2847 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2742 | 0.100 |
Why?
|
Leukemia, Hairy Cell | 1 | 2011 | 82 | 0.100 |
Why?
|
Receptor, Notch1 | 1 | 2014 | 521 | 0.090 |
Why?
|
Leukemia, B-Cell | 1 | 2011 | 86 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2015 | 460 | 0.090 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 13708 | 0.090 |
Why?
|
Immunoglobulin M | 3 | 2020 | 1529 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2964 | 0.070 |
Why?
|
Humans | 34 | 2024 | 768451 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3611 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11843 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4781 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2430 | 0.060 |
Why?
|
Bone Marrow | 3 | 2021 | 2929 | 0.060 |
Why?
|
Prognosis | 6 | 2024 | 30028 | 0.060 |
Why?
|
Aged | 14 | 2024 | 171520 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 17149 | 0.060 |
Why?
|
Survival Rate | 4 | 2021 | 12875 | 0.060 |
Why?
|
Hepatitis C | 1 | 2014 | 1594 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2019 | 1869 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2013 | 2594 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39430 | 0.050 |
Why?
|
Aged, 80 and over | 8 | 2021 | 59680 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Middle Aged | 14 | 2021 | 223418 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2021 | 1409 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2011 | 2072 | 0.050 |
Why?
|
Cell Survival | 2 | 2024 | 5801 | 0.050 |
Why?
|
Prospective Studies | 6 | 2021 | 54914 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4120 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2910 | 0.040 |
Why?
|
Paraproteins | 1 | 2020 | 38 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5808 | 0.040 |
Why?
|
Signal Transduction | 2 | 2020 | 23638 | 0.040 |
Why?
|
src-Family Kinases | 1 | 2022 | 539 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2024 | 65409 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2020 | 329 | 0.040 |
Why?
|
Female | 15 | 2024 | 396943 | 0.040 |
Why?
|
Boron Compounds | 1 | 2020 | 196 | 0.040 |
Why?
|
Male | 14 | 2024 | 364781 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6856 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6537 | 0.040 |
Why?
|
Adult | 11 | 2021 | 223542 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1839 | 0.040 |
Why?
|
Glycine | 1 | 2020 | 672 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2023 | 2525 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2020 | 329 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5709 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2633 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9425 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10125 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7605 | 0.030 |
Why?
|
Genomics | 2 | 2020 | 5909 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12561 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2258 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6135 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 6091 | 0.030 |
Why?
|
Drug Resistance | 1 | 2019 | 1599 | 0.030 |
Why?
|
Anthracyclines | 1 | 2015 | 286 | 0.030 |
Why?
|
Dexamethasone | 1 | 2020 | 1965 | 0.030 |
Why?
|
Vincristine | 1 | 2015 | 1039 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 695 | 0.020 |
Why?
|
Leucine | 1 | 2013 | 549 | 0.020 |
Why?
|
NF-kappa B | 1 | 2020 | 2491 | 0.020 |
Why?
|
Proline | 1 | 2013 | 456 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2046 | 0.020 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2013 | 179 | 0.020 |
Why?
|
Prednisone | 1 | 2015 | 1568 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2126 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1892 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 1 | 2013 | 531 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2224 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22293 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3665 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6890 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6816 | 0.020 |
Why?
|
Hepacivirus | 1 | 2014 | 1342 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9558 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1749 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11138 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1885 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2392 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13324 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13655 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.010 |
Why?
|
Mice | 2 | 2021 | 82045 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 13047 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7449 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8510 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13026 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9526 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18388 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40271 | 0.010 |
Why?
|
Animals | 2 | 2021 | 169418 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18048 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9623 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15880 | 0.010 |
Why?
|
United States | 1 | 2021 | 73121 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 81834 | 0.010 |
Why?
|